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Abstract: Background: The main purpose of the study was to establish whether essential components of the renin-
angiotensin system (RAS) exist in the human aqueous humor. 
Methods: Forty-five patients ≥ 60 (74±7) years of age undergoing cataract surgery at Tampere University Hospital were 
randomly selected for the prospective study. The exclusion criterion was the use of oral antihypertensive medicine acting 
via renin-angiotensin system. Aqueous humor samples were taken at the beginning of normal cataract extraction. The 
samples were frozen and stored at -80 °C. The concentrations of intraocular endogenous RAS components Ang(1-7), 
ACE2, and ACE1 were measured using ELISA. 
Results: Concentration medians of Ang(1-7), ACE2, and ACE1 in the aqueous humor were: Ang(1-7) 4.08 ng/ml, ACE2 
2.32 ng/ml and ACE1 0.35 ng/ml. The concentrations were significantly higher in glaucomatous than in non-
glaucomatous eyes, ACE1 (p=0.014) and Ang(1-7) (p=0.026) vs non-glaucomatous eyes. 
Conclusions: Ang(1-7), ACE2 and ACE1 are found in the human aqueous humor. The observations are consistent with 
the conception that local tissue-RAS exists in the human eye and it might have a role in the control of intraocular pressure. 
Keywords: Angiotensin (1-7), angiotensin converting enzyme 2, angiotensin II, angiotensin converting enzyme 1, aqueous 
humor, glaucoma, renin-angiotensin system. 
INTRODUCTION 
 The systemic renin-angiotensin system (RAS) controls 
fluid volume, electrolyte balance and blood pressure (BP) 
homeostasis [1]. RAS is also regarded as a tissue-specific 
regulatory system accounting for local effects and long-term 
changes in different organs [2, 3]. Many peptides and 
enzymes of RAS have already been detected in the human 
eye [2, 4, 5] and they are even suggested to have a role in the 
pathogenesis of different ocular diseases including glaucoma 
[6]. One of the major known risk factors for glaucoma is 
increased intraocular pressure (IOP) [7-9] which is a net sum 
of homeostatic balance between aqueous humor formation 
and outflow. 
 It has recently been reported that orally administered 
antihypertensive drugs can also reduce IOP [10]; for 
example, oral angiotensin converting enzyme (ACE) 
inhibitor (captopril) [11] and the AT1- receptor blocker 
(ARB) [12] (losartan) have been shown to lower IOP in both 
non-glaucomatous and glaucomatous patients. In animal 
studies, ACE inhibitors [13, 14] ARBs [15, 16], renin 
inhibitors [17] and angiotensin (1-7) [18] have been reported 
to lower IOP, even when they are locally administered. 
These findings imply that a local intraocular RAS may be 
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involved in the regulation of IOP [19, 20]. Recently, other 
broader theories have been published on RAS involvement 
in the pathogenesis of glaucoma [6, 21]. So far, only AngII 
and ACE1 have been identified in the human aqueous humor 
[6, 22]. RAS is known to consist of over twenty peptidases, 
close to twenty angiotensin peptides, and at least six 
receptors [23]. AngII-ACE1-angiotensin 1 receptor type 
(AT1R)-axis together with Ang(1-7)-ACE2-Mas-receptor 
(MasR)-axis are seen as the main pathways of RAS that may 
mediate therapeutic benefits. The main purpose of this study 
was to detect the levels of Ang(1-7), ACE2 and ACE1 
qualitatively and quantitatively in the human aqueous humor. 
MATERIALS AND METHODOLOGY 
 The study was undertaken in the Department of 
Ophthalmology in the University Hospital of Tampere, 
Finland between 28th February and 8th April 2014. The study 
conforms to the World Medical Association Declaration of 
Helsinki and the Ethical Principles for Medical Research 
Involving Human Subjects, and received approval from the 
Regional Ethics Committee at Tampere (ETL R14010). 
Informed consent was obtained from all participants. Patients 
over 60 years of age undergoing cataract surgery were 
included. The patients were selected randomly from the 
cataract operation list and they were operated upon by the 
same surgeon. The only exclusion criterion was the use of 
oral antihypertensive medicine acting via renin-angiotensin 
system. Together, 45 patients were operated upon; 15 of 
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them had been diagnosed with glaucoma according to 
Finnish Evidence- Based Guidelines [9]. All the 
glaucomatous patients were ocular normotensive because of 
continuous antiglaucoma medication or previous glaucoma 
surgery. Thus all the eyes independently of medication were 
normotensive, and the division to glaucomatous/non-
glaucomatous was based on the history of the patients. 
Medical records (age, gender, medications and IOP) were 
registered during the preoperative visit. IOP was measured 
using a rebound tonometer (Icare®, Icare Finland Oy, Vantaa, 
Finland). Blood pressure was measured three consecutive 
times prior to surgery in sitting position and the average of 
the measurements was calculated. 
 An additional eleven patients were operated upon; six of 
them were taking oral ACE inhibitor medication for high 
blood pressure and five of them were on ARBmedication. 
These patients were not included in the main study results, 
but their anterior chamber RAS component concentrations 
are shown in Fig. (1). 
 Aqueous humor samples (0.05-0.35 ml) were taken in the 
beginning of routine cataract surgery. The liquid was 
collected into Eppendorf tubes and immediately chilled in an 
icebox. After the operation, the collected samples were 
frozen and stored at -80°C within 2 h. No protease/peptidase 
inhibitors were added in the collection and storage of the 
samples. The samples were analyzed using commercially 
available enzyme-linked immunosorbent assays (ELISA) 
due to their applicability to simultaneously assess the target 
molecule concentrations in a large number of samples. 
Ang(1-7) was measured using the Human Angiotensin(1-7) 
Elisa kit (MyBioSource, San Diego, CA, USA) with a 
detection limit of 0.1 ng/ml. ACE2 was measured using the 
Human ACE2 ELISA kit (Boster Immunoleader, Pleasanton, 
CA, USA) with a detection limit of <10 pg/ml, ACE1 using 
the Human ACE ELISA kit (Boster Immunoleader) with a 
detection limit of <5 pg/ml. AngII was also measured using 
the Angiotensin II ELISA kit (Enzo Life Sciences, 
Farmingdale, NY, USA) with a detection limit of 4.6 pg/ml. 
The kits were designed for usage with human serum, plasma, 
cell culture supernates, body fluid or tissue homogenates. 
The assay procedures and assays were conducted according 
to manufacturers’ instructions. Only Angiotensin II ELISA 
kit has been shown to have cross-reactivity, but it is of no 
relevance. In other ELISA kits cross-reactions were 
negligible. All assays were done blinded. Results are shown 
in ng/ml. 
 The data from the ELISA assays were analyzed using 
Microsoft Excel and SPSS Statistics for Windows ver. 21.0. 
(IBM Corp, Armonk, NY, USA). Nonparametric Mann-
Whitney test and Spearman's Correlation were used for data 
with skewed distribution and the results are shown as median 
with upper and lower quartiles, whereas independent sample 
t-test and Pearson’s Correlation were used for normally 
distributed data. The results are shown as mean ±SD. The 
level of significance was set at ˂0.05 (two-tailed) in all 
statistical tests. 
RESULTS 
 Forty-six aqueous humor samples were analyzed from 45 
subjects with an average age of 74±7 (mean ± SD) years. Of 
these, 27 (60 %) were female and 18 (40 %) male. Fifteen 
were diagnosed with glaucoma and 30 were non-
glaucomatous. Overall demographics of the glaucomatous 
and non-glaucomatous subgroups are presented in Table 1. 
Table 1. Demographics and intracameral concentrations of 
Ang(1-7), ACE2 and ACE1. For normally 
distributed data results are shown as mean ±SD, for 
skewly distributed data median with upper and 
lower quartiles. The small volume of some samples 
did not allow all measurements. 
 
  Non-Glaucomatous  (n = 30) † 
Glaucomatous  
(n = 15) p-Value  
Age 74 ± 7 75 ± 8 0.843 
Gender (M/W) 10/20 8/7   
IOP 15 ± 4 16 ± 6 0.658 
Systolic BP 163 ± 21 166 ± 26 0.692 
Diastolic BP 88 ± 10 92 ± 11 0.335 
Ang(1-7) 
3.81 4.53 0.026* 
(3.69-4.59) (4.03-6.21) 
 
(n = 31) (n = 15)   
ACE2 
2.26 2.96 0.409 
(1.19-6.02) (1.91-12.33) 
 
(n = 20) (n = 14)   
ACE1 
0.27 0.48 0.014* 
(0.23-0.39) (0.33-0.79) 
 
(n = 20) (n = 12)   
†Number of patients: n=30, number of eyes: n=31. * p-value<0.05. 
Ang(1-7), angiotensin (1-7); ACE1, -2, angiotensin- converting enzyme 1, -2; BP, 
blood pressure; IOP, intraocular pressure; M, men; W, women. 
 
 Median aqueous humor (n=46) Ang(1-7), ACE2 and 
ACE1 concentrations were: 4.08 ng/ml (Q1-Q3; 4.00-4.92), 
2.32 ng/ml (Q1-Q3; 2.58-7.53) and 0.35 ng/ml (Q1-Q3; 
0.30-0.51), respectively. None of the samples showed 
measurable levels of AngII. The Ang(1-7) and ACE1 
concentrations were significantly higher in glaucomatous 
than in non-glaucomatous eyes (p=0.026 and p=0.014). See 
Table 1. Individual aqueous humor concentrations of Ang(1-
7), ACE2 and ACE1 in non-glaucomatous and glaucomatous 
patients are presented in Fig. (1). 
 Age, IOP- and BP-values did not differ between the two 
subgroups (Table 1). With one exception, no significant 
differences between men and women were found in Ang(1-
7), ACE2 or ACE1 concentrations in the subgroups (Table 
2). The significant correlations were in the non-
glaucomatous group ACE1 vs age and ACE1 vs ACE2 both 
genders together. In glaucomatous patients no correlations 
were found. 
 Glaucoma patients (n=15) used different topically 
administered antiglaucoma drugs. Patients who used 
prostaglandin analogues had higher Ang(1-7) and ACE1 
concentrations vs patients with no medication (p=0.012 and 
p=0.028 respectively). Also, the use of a combination of beta 
blocker and carbonic anhydrase inhibitor was associated 
with higher ACE1 concentration (p=0.035). No statistically 
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significant difference was detected between patients using 
other glaucoma medications. 
DISCUSSION 
 The present study was aimed to detect the central 
components of RAS in the human aqueous humor. In 
addition possible differences between glaucomatous and 
non-glaucomatous eyes were studied. We showed that 
endogenous Ang(1-7) and ACE1 and ACE2 are present in 
the aqueous humor of the human eye. The glaucomatous 
eyes have higher levels of ACE1 vs non-glaucomatous eyes. 
This would suggest a role of ACE1 in IOP balance in the 
development of glaucoma. Furthermore, ACE1 levels were 
associated with higher ACE2 concentrations in non-
glaucomatous eyes, this offsetting each other's effects on 
IOP. Interestingly, in the glaucomatous subjects age did not 
correlate with the aqueous humor concentrations of any of 
the RAS components, while in non-glaucomatous eyes 
increasing age was with higher ACE1 concentrations. 
Aqueous humor Ang(1-7), ACE1 and ACE2 levels did not 
differ between the genders in either of the subgroups. BP and 
IOP values were not associated with higher RAS component 
concentrations. High BP values measured just before surgery 
were likely to result from the anxiety and fear that patients 
usually feel prior to an operation. On the other hand, all 
glaucomatous patients were under treatment and therefore 
had normal IOP values. 
 The lack of measurable levels of AngII in aqueous humor 
samples may be explained by the absence of 
protease/peptidase inhibitors in the collection and storage of 
the samples. Thus AngI (DRVYIHPFHL) and AngII 
(DRVYIHPF) peptides can be cleaved to shorter angiotensin 
peptides [24]; to AngIII (RVYIHPF) or Ang(1-9) 
(DRVYIHPFH) or Ang(1-7) (DRVYIHP) [2]. For example, 
prolyl endopeptidase and prolyl carboxypeptidase can 
hydrolyze AngII to Ang(1-7). These alternative pathways of 
angiotensin degradation system are possible. In previous 
studies [4] intraocular AngII detection measurements were 
performed in pools consisting of different samples. It is also 
possible that the sensitivity of the used AngII assay was too 
weak in this study. Unfortunately, there is no reference to 
literature showing a rigorous assessment of these kits. 
Usually, ELISA methods are qualitative and quantitative but 
they need highly specific and sensitive antibodies. Because 
the sensitivity of the assays is strictly limited by the affinity 
between antibodies, peptides, and proteins, it is not possible 
in practice to accurately validate or tune assays. 
 Interestingly, subjects who used prostaglandin analogues 
as glaucoma medication had higher Ang(1-7) and ACE1 
concentrations. In addition, the use of a combination of beta 
 
Fig. (1). Individual aqueous humor concentrations of Ang(1-7), ACE2 and ACE1 in non-glaucomatous (white open circles) and 
glaucomatous (black spots) patients. Comparison with Mann-Whitney test, *p<0.05. Patients using ACE inhibitors (plus marks) or AT-
receptor blockers (x marks) are also shown; these patients were excluded from the data in determination of the median concentrations 
(horizontal lines). For abbreviations see Table 1. 
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blocker + carbonic anhydrase inhibitor was associated with 
higher ACE1 concentrations. Due to the limited number of 
patients using glaucoma medications in the present study, 
these observations require further confirmation. 
CONCLUSION 
 Angiotensin(1-7) and ACE2, the “hot spots” in the renin-
angiotensin system, are found in the human aqueous humor. 
This supports the assumption that intraocular RAS may be 
involved in the regulation of IOP. This theory is further 
strongly supported by our very recent observation [25] on the 
expression of Mas-receptors in the retina and especially in 
the anterior part of the human eye. 
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